United States

Essex Bio-Technology Ltd (1061.HK)

1061.HK on Hong Kong Stock

20 Sep 2017
Change (% chg)

HK$0.02 (+0.38%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Essex Bio-Technology posts HY profit attributable of HK$77.1 mln
Friday, 11 Aug 2017 07:58am EDT 

Aug 11 (Reuters) - Essex Bio-technology Ltd <1061.HK>:HY profit attributable HK$77.1 million versus HK$62 million.HY turnover HK$437.6 million versus HK$363.9 million.Has resolved on 11 August 2017 to declare an interim dividend of HK$0.025 per share for six months ended 30 June 2017.  Full Article

Essex Bio-Technology announces approval to commercialise Tobramycin eye drops in China
Tuesday, 13 Jun 2017 06:06am EDT 

June 13 (Reuters) - Essex Bio-technology Ltd <1061.HK> ::Announces approval to commercialise preservative-free single-dose Tobramycin eye drops in China.Approved product is expected to be launched in market at or around end of 2017.  Full Article

Essex Bio-Technology Ltd updates on collaboration and license agreement
Sunday, 24 Jan 2016 07:51pm EST 

Essex Bio-Technology Ltd:Tech-inside information - collaboration and license agreement and proposed subscription of series c preferred stock and warrants.Says Essex Bio investment and Abpro entered into the collaboration and license agreement.Parties agreed to commercialise and jointly develop selected antibodies into licensed products.The collaboration and license agreement is for an initial term of 10 years.Essex Bio investment and abpro entered into the share subscription agreement.Abpro conditionally agreed to issue, 616,197 series c preferred stock for a total consideration of approximately US$3.5 million.  Full Article